Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
GALVmed has received funding totaling $19 million for its Improved Tools for the Control of Animal African Trypanosomosis, Phase 3 (Tryps 3) program.
Subscribers have five weeks to nominate their company and their innovations in the Animal Pharm Awards for 2018.
US firm Zomedica Pharmaceuticals has seen its net loss in the third quarter of 2018 decrease.
Zoetis has gained US FDA approval for its Cyden (clopidol) and Lincomix (lincomycin) combination feed additive.
Ceva Santé Animale's Isemid (torasemide) has moved a step closer to European authorization after gaining a recommendation for marketing approval.
Litecure has advanced towards commercialization of Companion Nano Therapy with a potential launch date in the US of 2019.
A global clash over the use of beta-agonist livestock growth promoters is once again prompting US criticism of international organizations.
Kindred Biosciences has gained positive top-line results from a pilot effectiveness study of its interleukin-31 (IL-31) antibody for the treatment of canine atopic dermatitis.
Phyto Animal Health has signed an exclusive distribution agreement with Liiv Organics to sell its cannabidiol (CBD) products in the US.
Industry body AnimalhealthEurope has welcomed new rules for animal medicines signed off by European Parliament.
ELIAS Animal Health claims a new study suggests its experimental cancer immunotherapy "may improve survival times in dogs with cancer".
Several key trends have aligned to make the animal health and welfare sector a truly attractive prospect, according to venture capital investor Anterra Capital.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.